These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 37000699)
1. Opportunities and challenges in targeting orphan nuclear receptors. Isigkeit L; Merk D Chem Commun (Camb); 2023 Apr; 59(31):4551-4561. PubMed ID: 37000699 [TBL] [Abstract][Full Text] [Related]
2. ONRLDB--manually curated database of experimentally validated ligands for orphan nuclear receptors: insights into new drug discovery. Nanduri R; Bhutani I; Somavarapu AK; Mahajan S; Parkesh R; Gupta P Database (Oxford); 2015; 2015():. PubMed ID: 26637529 [TBL] [Abstract][Full Text] [Related]
3. Structures and regulation of non-X orphan nuclear receptors: A retinoid hypothesis. Zhi X; Zhou XE; Melcher K; Xu HE J Steroid Biochem Mol Biol; 2016 Mar; 157():27-40. PubMed ID: 26159912 [TBL] [Abstract][Full Text] [Related]
4. ROR nuclear receptors: structures, related diseases, and drug discovery. Zhang Y; Luo XY; Wu DH; Xu Y Acta Pharmacol Sin; 2015 Jan; 36(1):71-87. PubMed ID: 25500868 [TBL] [Abstract][Full Text] [Related]
5. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer. Garattini E; Bolis M; Gianni' M; Paroni G; Fratelli M; Terao M Oncotarget; 2016 Jul; 7(27):42661-42682. PubMed ID: 26894976 [TBL] [Abstract][Full Text] [Related]
6. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers. Roshan-Moniri M; Hsing M; Butler MS; Cherkasov A; Rennie PS Cancer Treat Rev; 2014 Dec; 40(10):1137-52. PubMed ID: 25455729 [TBL] [Abstract][Full Text] [Related]
12. The emerging roles of liver X receptors and their ligands in cancer. Lin CY; Vedin LL; Steffensen KR Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589 [TBL] [Abstract][Full Text] [Related]
13. Oxysterols and nuclear receptors. Ma L; Nelson ER Mol Cell Endocrinol; 2019 Mar; 484():42-51. PubMed ID: 30660701 [TBL] [Abstract][Full Text] [Related]
14. Probing the orphan receptors: Tools and directions. Franchini L; Orlandi C Prog Mol Biol Transl Sci; 2023; 195():47-76. PubMed ID: 36707155 [TBL] [Abstract][Full Text] [Related]
15. Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Burris TP; Busby SA; Griffin PR Chem Biol; 2012 Jan; 19(1):51-9. PubMed ID: 22284354 [TBL] [Abstract][Full Text] [Related]
16. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. Safe S; Jin UH; Hedrick E; Reeder A; Lee SO Mol Endocrinol; 2014 Feb; 28(2):157-72. PubMed ID: 24295738 [TBL] [Abstract][Full Text] [Related]
17. Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics. Solt LA; Griffin PR; Burris TP Curr Opin Lipidol; 2010 Jun; 21(3):204-11. PubMed ID: 20463469 [TBL] [Abstract][Full Text] [Related]
18. Design of a Potent TLX Agonist by Rational Fragment Fusion. Faudone G; Zhubi R; Celik F; Knapp S; Chaikuad A; Heering J; Merk D J Med Chem; 2022 Feb; 65(3):2288-2296. PubMed ID: 34989568 [TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors as drug targets for metabolic disease. Schulman IG Adv Drug Deliv Rev; 2010 Oct; 62(13):1307-15. PubMed ID: 20655343 [TBL] [Abstract][Full Text] [Related]